We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRVN icon
2426
Driven Brands
DRVN
$2.12B
$258K ﹤0.01%
9,506
-174
-2% -$4.84K
KURA icon
2427
Kura Oncology
KURA
$896M
$258K ﹤0.01%
24,368
+608
+3% +$7.19K
MTRX icon
2428
Matrix Service
MTRX
$328M
$257K ﹤0.01%
43,511
+4,800
+12% +$26.3K
UTI icon
2429
Universal Technical Institute
UTI
$1.42B
$257K ﹤0.01%
37,115
+321
+0.9% +$2.16K
HIPO icon
2430
Hippo Holdings
HIPO
$869M
$256K ﹤0.01%
15,450
-1,031
-6% -$17.9K
CPF icon
2431
Central Pacific Financial
CPF
$1B
$255K ﹤0.01%
16,224
+458
+3% +$7.21K
MPAA icon
2432
Motorcar Parts of America
MPAA
$235M
$254K ﹤0.01%
32,700
+1,057
+3% +$6.04K
VIPS icon
2433
Vipshop
VIPS
$6.8B
$254K ﹤0.01%
15,330
-2,770
-15% -$43.4K
VSEC icon
2434
VSE Corp
VSEC
$6.48B
$254K ﹤0.01%
4,632
+131
+3% +$6.33K
FET icon
2435
Forum Energy Technologies
FET
$927M
$251K ﹤0.01%
+9,793
New +$232K
AMWL icon
2436
American Well
AMWL
$220M
$250K ﹤0.01%
5,947
+247
+4% +$10.9K
GOOD
2437
Gladstone Commercial Corp
GOOD
$641M
$250K ﹤0.01%
20,173
+546
+3% +$6.55K
FLXS icon
2438
Flexsteel Industries
FLXS
$303M
$249K ﹤0.01%
12,600
LXRX icon
2439
Lexicon Pharmaceuticals
LXRX
$1.04B
$249K ﹤0.01%
108,386
-48,235
-31% -$128K
PSTL
2440
Postal Realty Trust
PSTL
$701M
$249K ﹤0.01%
16,921
+616
+4% +$9.11K
TSE
2441
DELISTED
Trinseo
TSE
$249K ﹤0.01%
19,644
+358
+2% +$5.78K
ACHR icon
2442
Archer Aviation
ACHR
$5.37B
$248K ﹤0.01%
60,096
+32,431
+117% +$91.5K
CDZI icon
2443
Cadiz
CDZI
$295M
$248K ﹤0.01%
61,025
-5,947
-9% -$26.3K
ARAY icon
2444
Accuray
ARAY
$32.9M
$246K ﹤0.01%
63,417
-131,577
-67% -$456K
HROW icon
2445
Harrow
HROW
$1.46B
$246K ﹤0.01%
12,873
+2,973
+30% +$65.4K
GTES icon
2446
Gates Industrial Corporation Ltd.
GTES
$7B
$245K ﹤0.01%
18,120
+1,336
+8% +$17.3K
SFIX
2447
Stitch Fix
SFIX
$487M
$245K ﹤0.01%
63,516
+510
+0.8% +$1.93K
PNT
2448
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$245K ﹤0.01%
26,973
-9,820
-27% -$86.6K
FRST icon
2449
Primis Financial Corp
FRST
$413M
$244K ﹤0.01%
28,960
ICPT
2450
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$243K ﹤0.01%
21,963
+384
+2% +$5.35K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.